Francis Knuettel II

SEC Form 4 insider trading activity

Francis Knuettel II has filed 5 SEC Form 4 filings (6 transaction rows) across 2 companies, including BLNE, PTHS, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 1, 2026.

On the most recent filing, Francis Knuettel II is listed as CFO, Treas & Secty at Pelthos Therapeutics Inc. Inside the rolling window, Francis Knuettel II reported no open-market purchases and 1 open-market sale totaling $40K in PTHS.

Companies traded

Other insiders at BLNE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$40K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
PTHS
Francis Knuettel II
Sale$40KMay 26SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Francis Knuettel II made?

Francis Knuettel II has filed 5 SEC Form 4 filings (6 transaction rows) across 2 companies, including BLNE, PTHS since 2025.

Which companies does Francis Knuettel II trade?

Francis Knuettel II has filed SEC Form 4 disclosures for 2 companies, including BLNE, PTHS.

When was Francis Knuettel II's most recent SEC Form 4 filing?

Francis Knuettel II's most recent SEC Form 4 filing on Tracefour is dated Jun 1, 2026.

What is Francis Knuettel II's total buy and sell value in the current window?

Inside the rolling retention window, Francis Knuettel II bought $0 and sold $40K based on SEC Form 4 filings.

What was Francis Knuettel II's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,500 PTHS shares on 2026-05-22, worth $40K, per SEC Form 4 filings.